Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer’s disease, giving a fresh target for research into treatments for the mind-robbing disorder.
The problem gene is not common — less than 1 percent of people are thought to have it — but it roughly triples the chances of developing Alzheimer’s compared to people with the normal version of the gene. It also seems to harm memory and thinking in older people without dementia.
The main reason scientists are excited by the discovery is what this gene does, and how that might reveal what causes Alzheimer’s and ways to prevent it. The gene helps the immune system control inflammation in the brain and clear junk such as the sticky deposits that are the hallmark of the disease. Mutations in the gene may impair these tasks, so treatments to restore the gene’s function and quell inflammation may help.
“It points us to potential therapeutics in a more precise way than we’ve seen in the past,” said Dr. William Thies, chief medical and scientific officer of the Alzheimer’s Association, which had no role in the research. Years down the road, this discovery will likely be seen as very important, he predicted.
It is described in a study by an international group published online Wednesday by the New England Journal of Medicine.
About 35 million people worldwide have dementia, and Alzheimer’s is the most common type. In the U.S., about 5 million have Alzheimer’s. Medicines such as Aricept and Namenda just temporarily ease symptoms. There is no known cure.
Until now, only one gene — ApoE — has been found to have a big impact on Alzheimer’s risk. About 17 percent of the population has at least one copy of the problem version of this gene but nearly half of all people with Alzheimer’s do. Other genes that have been tied to the disease raise risk only a little, or cause the less common type of Alzheimer’s that develops earlier in life, before age 60.
The new gene, TREM2, already has been tied to a couple other forms of dementia. Researchers led by deCODE Genetics Inc. of Iceland honed in on a version of it they identified through mapping the entire genetic code of more than 2,200 Icelanders.
Further tests on 3,550 Alzheimer’s patients and more than 110,000 people without dementia in several countries, including the United States, found that the gene variant was more common in Alzheimer’s patients.
“It’s a very strong effect,” raising the risk of Alzheimer’s by three to four times — about the same amount as the problem version of the ApoE gene does, said Dr. Allan Levey, director of an Alzheimer’s program at Emory University, one of the academic centers participating in the research.
Researchers also tested more than 1,200 people over age 85 who did not have Alzheimer’s disease and found that those with the variant TREM2 gene had lower mental function scores than those without it. This adds evidence the gene variant is important in cognition, even short of causing Alzheimer’s.
“It’s another piece in the puzzle. It suggests the immune system is important in Alzheimer’s disease,” said Andrew Singleton, a geneticist with the National Institute on Aging, which helped pay for the study.
One prominent scientist not involved in the study — Dr. Rudolph Tanzi, a Harvard Medical School geneticist and director of an Alzheimer’s research program at Massachusetts General Hospital — called the work exciting, but added a caveat.
“I would like to see more evidence that this is Alzheimer’s” rather than one of the other dementias already tied to the gene, Tanzi said. Autopsy or brain imaging tests can show whether the cases attributed to the gene variant are truly Alzheimer’s or misdiagnosed, he said.
Online:
Medical journal
Alzheimer’s info
Alzheimer’s Association
Marilynn Marchione can be followed on Twitter
Health
New gene triples risk for Alzheimer’s disease
- Health
-
-
Her Doctor Dismissed the Lump in Her Breast
It was on the weekend of my 25th birthday that my boyfriend alerted me to a lump in my left breast. At first dismissive of his concern, I eventually promised to see my gynecologist. I was due for my annual exam anyway.
-
Tenn. hospital treats drug-dependent babies
He's less than two weeks old, but he shows the telltale signs of a baby agitated and in pain: an open sore on his chin where he's rubbed the skin raw, along with a scratch on his left check.
-
‘Fibro Fighter’ struggles with fatigue, debilitating pain
For some people life is a little more complicated than the normal rushing around with kids, doing errands, being on time for work and other everyday routines that consume most of our waking moments.
-
AP Exclusive: Calif. exchange granted secrecy
A California law that created an agency to oversee national health care reforms granted it broad authority to conceal spending on the contractors that will perform most of its functions, potentially shielding the public from seeing how hundreds of millions of dollars are spent.
-
Drugmakers, health groups bring poor girls vaccine
Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer.
-
Study: Fish oil doesn’t help prevent heart attacks
Eating fish is good for your heart but taking fish oil capsules does not help people at high risk of heart problems who are already taking medicines to prevent them, a large study in Italy found.
-
Most and least-fit states in the U.S.
A new report released by the Centers for Disease Control highlights adult fitness levels based on participation in aerobic and muscle-building activities. Find out which states came in with the fittest and least-fit populations.
-
Bashful? Buy the little blue pill online
Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill.
-
FDA wants cancer warnings on tanning beds
Indoor tanning beds would come with new warnings about the risk of cancer and be subject to more stringent federal oversight under a proposal unveiled Monday by the Food and Drug Administration.
-
The Lifefirst family
Young Vincent Karolewics dreamed of becoming a naval fighter pilot.
- More Health Headlines
-
Raw: Widespread Destruction in Moore, Okla.
Raw: Massive Funnel Clouds in Oklahoma
Raw: Japan's WWII Atrocities Under Fire in Seoul
Voters Could Elect LA's First Female Mayor
Raw: Rescuers Pull Tornado Survivors to Safety
Oklahoma Gov: 'Hearts Are Broken' After Tornado
Raw: Walking in a Flattened Okla. Neighborhood
Raw: Rescue Workers Search Oklahoma School
Raw: Witness Describes Scene After Okla. Tornado
Raw: Aftermath of Massive Tornado in Oklahoma
Raw: House Burns After Massive Oklahoma Tornado
Raw: Tornado on the Ground in Oklahoma
Split-second Choice Ended With NY Student Dead
White House Backs 'Shield Law' for Media
Wave of Attacks Kills Scores in Iraq
Pug Life on Display at Wisconsin Festival
Company Promises to Make All Snail Mail Digital
Analyst: Tumblr Fills Void in Yahoo's Offerings
